SR
Srinivasa Ramachandra Rao Ilapakurthy
About Srinivasa Ramachandra Rao Ilapakurthy
Data last updated:
Srinivasa Ramachandra Rao Ilapakurthy is a Director at Gls Pharma Limited (since 2023), Director at Lyfius Pharma Private Limited (since 2024) and Director at Auro Pharma Limited (since 2023). The companies operate in Pharma, Chemicals and Real Estate and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹36.10 Cr; the largest is Gls Pharma Limited at ₹36.08 Cr (FY 2023). Earlier, Srinivasa Ramachandra Rao Ilapakurthy was a Designated Partner at Service First Experts Llp (2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 15 Dec 2023 | 2004 | ₹36.08 Cr (FY 2023) | Active | |
| Director | 30 Jan 2024 | 2020 | ₹2 Lakh (FY 2023) | Active | |
| Director | 22 Nov 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 16 Jan 2023 | 2023 | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Srinivasa Ramachandra Rao Ilapakurthy
| Name | DIN | Company | Designation |
|---|---|---|---|
| Pendem Harish Babu | 05221219 | Gls Pharma Limited , Auro Pharma Limited | Additional Director |
| Ravikiran Namburi | 10780420 | Gls Pharma Limited | Director |
| Bala Subramanyam Sami Reddy Palle Reddy | 10766723 | Lyfius Pharma Private Limited | Additional Director |
| Medisetti Venkata Ramakrishna | 09581841 | Lyfius Pharma Private Limited | Whole-Time Director |
| Nityananda Reddy Kambam | 01284195 | Lyfius Pharma Private Limited | Director |
| Santhanam Subramanian | 03516515 | Lyfius Pharma Private Limited | Director |
| Ranjit Kumar Gulla | 10352433 | Auro Pharma Limited | Director |
| Thomas Koshy Vellutheril | 10352403 | Auro Pharma Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Srinivasa Ramachandra Rao Ilapakurthy
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Srinivasa Ramachandra Rao Ilapakurthy
Srinivasa Ramachandra Rao Ilapakurthy currently holds 3 directorships: Gls Pharma Limited (Director, since 15 Dec 2023, revenue ₹36.08 Cr (FY 2023)); Lyfius Pharma Private Limited (Director, since 30 Jan 2024, revenue ₹2 Lakh (FY 2023)); Auro Pharma Limited (Director, since 22 Nov 2023).
Srinivasa Ramachandra Rao Ilapakurthy was first appointed on 16 Jan 2023 as Designated Partner at Service First Experts Llp. The most recent appointment on record is 30 Jan 2024 at Lyfius Pharma Private Limited.
The 2 current companies of Srinivasa Ramachandra Rao Ilapakurthy that report revenue have a combined latest revenue of ₹36.10 Cr: Gls Pharma Limited ₹36.08 Cr (FY 2023); Lyfius Pharma Private Limited ₹2 Lakh (FY 2023).
Srinivasa Ramachandra Rao Ilapakurthy held 1 earlier board appointment: Service First Experts Llp (Designated Partner, 16 Jan 2023 to 07 Jul 2023).
The current boards of Srinivasa Ramachandra Rao Ilapakurthy's companies include Pendem Harish Babu (Gls Pharma Limited), Ravikiran Namburi (Gls Pharma Limited), Bala Subramanyam Sami Reddy Palle Reddy (Lyfius Pharma Private Limited), Medisetti Venkata Ramakrishna (Lyfius Pharma Private Limited), Nityananda Reddy Kambam (Lyfius Pharma Private Limited), Santhanam Subramanian (Lyfius Pharma Private Limited), among others.